BioCardia CEO Peter Altman Buys 1,000 Shares

What Happened Peter Altman, President, CEO and Director of BioCardia, Inc. (BCDA), reported an open-market purchase of 1,000 shares on 2026-09-29. The Form 4 shows a weighted-average price of $1.03 per share for a total of $1,030. This was a purchase (transaction code P), which investors often view as a modest insider buy.

Key Details

• Transaction date: 2026-09-29; Form 4 filed 2026-09-30 (appears timely).
• Shares purchased: 1,000 at a weighted-average price of $1.03; total value $1,030.
• Reported price range: trades executed between $1.02 and $1.05 per share (see footnote).
• Shares owned after transaction: not provided in the supplied filing details.
• Footnote: the purchase occurred in multiple trades at prices from $1.02–$1.05; the filer can provide per-trade breakdown on request (Footnote F1).

Context This was a straightforward open-market buy (not an option exercise, gift, or tax withholding). The dollar amount is small relative to typical insider transactions, so interpret the signal accordingly. The filing appears timely (filed the next day).